BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29105289)

  • 1. Predictors of care for patients with cancer of unknown primary site in three Australian hospitals.
    Tan SYS; O'Neill S; Goldstein D; Ward RL; Daniels B; Vajdic CM
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e512-e520. PubMed ID: 29105289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP).
    Schaffer AL; Pearson SA; Perez-Concha O; Dobbins T; Ward RL; van Leeuwen MT; Rhee JJ; Laaksonen MA; Craigen G; Vajdic CM
    PLoS One; 2020; 15(3):e0230373. PubMed ID: 32191753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study in Australian Government Department of Veterans' Affairs clients.
    Vajdic CM; Schaffer AL; Dobbins TA; Ward RL; Er CC; Pearson SA
    Cancer Epidemiol; 2015 Aug; 39(4):585-92. PubMed ID: 26088263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of care and survival after a cancer of unknown primary (CUP) diagnosis: A population-based nested cohort study in Australian Government Department of Veterans' Affairs clients.
    Schaffer AL; Pearson SA; Dobbins TA; Er CC; Ward RL; Vajdic CM
    Cancer Epidemiol; 2015 Aug; 39(4):578-84. PubMed ID: 26100364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does patient age still affect receipt of adjuvant therapy for colorectal cancer in New South Wales, Australia?
    Jorgensen ML; Young JM; Dobbins TA; Solomon MJ
    J Geriatr Oncol; 2014 Jul; 5(3):323-30. PubMed ID: 24656735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of metastatic neoplasms with unknown primary.
    Bochtler T; Löffler H; Krämer A
    Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.
    Luke C; Koczwara B; Karapetis C; Pittman K; Price T; Kotasek D; Beckmann K; Brown MP; Roder D
    Aust N Z J Public Health; 2008 Aug; 32(4):383-9. PubMed ID: 18782405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists.
    Karapetis CS; Guccione L; Tattersall MH; Gooden H; Vajdic CM; Lambert S; Robotin M; Mileshkin L; Schofield P
    Intern Med J; 2017 Apr; 47(4):408-414. PubMed ID: 28101916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Cohort of Referrals to a Cancer of Unknown Primary Clinic, including Direct Access from Primary Care.
    Creak A
    Clin Oncol (R Coll Radiol); 2020 Apr; 32(4):e87-e92. PubMed ID: 31635979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP).
    Vajdic CM; Perez-Concha O; Dobbins T; Ward RL; Schaffer AL; van Leeuwen MT; Rhee JJ; Laaksonen MA; Craigen G; Pearson SA
    Cancer Epidemiol; 2019 Jun; 60():156-161. PubMed ID: 31015097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.
    Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR
    Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data.
    Vajdic CM; Er CC; Schaffer A; Dobbins T; Wyld L; Meagher NS; Barrett J; Ward RL; Pearson SA
    Cancer Epidemiol; 2014 Aug; 38(4):460-4. PubMed ID: 24929356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related predictors of cancer registry-notified cancer of unknown primary site (CUP).
    Vajdic CM; Perez-Concha O; Rhee JJ; Dobbins T; Ward RL; Schaffer AL; van Leeuwen MT; Laaksonen MA; Craigen G; Pearson SA
    Cancer Epidemiol; 2019 Aug; 61():1-7. PubMed ID: 31082704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival.
    Dumbrava MI; Burmeister EA; Wyld D; Goldstein D; O'Connell DL; Beesley VL; Gooden HM; Janda M; Jordan SJ; Merrett ND; Payne ME; Waterhouse MA; Neale RE
    Asia Pac J Clin Oncol; 2018 Aug; 14(4):326-336. PubMed ID: 29573158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in out-of-hospital death among palliative care inpatients across public hospitals in New South Wales, Australia.
    Assareh H; Stubbs JM; Trinh LTT; Muruganantham P; Achat HM
    Intern Med J; 2019 Apr; 49(4):467-474. PubMed ID: 30043405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of carcinoma of unknown primary in the head and neck.
    Issing WJ; Taleban B; Tauber S
    Eur Arch Otorhinolaryngol; 2003 Sep; 260(8):436-43. PubMed ID: 12684829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hospital-based services used by adults during the last year of life in New South Wales, Australia: a population-based retrospective cohort study.
    Goldsbury DE; O'Connell DL; Girgis A; Wilkinson A; Phillips JL; Davidson PM; Ingham JM
    BMC Health Serv Res; 2015 Dec; 15():537. PubMed ID: 26637373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma.
    Schapira DV; Jarrett AR
    Arch Intern Med; 1995 Oct; 155(19):2050-4. PubMed ID: 7575063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative care and psychosocial care in metastatic non-small cell lung cancer: factors affecting utilisation of services and impact on patient survival.
    Duggan KJ; Wiltshire J; Strutt R; Boxer MM; Berthelsen A; Descallar J; Vinod SK
    Support Care Cancer; 2019 Mar; 27(3):911-919. PubMed ID: 30066201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of a metastatic malignancy of unknown primary origin service led by a palliative physician.
    Brooks D; Hughes P; Farrington C; Bath PA; McGregor M; Ahmed W; Noble B
    Hosp Pract (1995); 2018 Feb; 46(1):37-42. PubMed ID: 29285946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.